An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease
Clinical trial NCT07438405 · RECRUITING
Trial details
- NCT number
- NCT07438405
- Sponsor
- Amgen
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-07
- Primary completion
- 2028-01-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.